Vimian acquires animal pharmaceuticals company in the UK

January 29, 2022

Today Vimian Group signed an agreement to acquire Bova Holdings Limited (Bova), a leading companion animal health specialty pharmaceuticals company in the United Kingdom. The company offers customised specialty pharmaceuticals for companion animals.

Established in 2017, Bova offers specialty pharmaceuticals covering a wide and expanding range of product classes. The company has more than 100 specialty pharmaceutical formulations, all raw materials and products are compliant with quality standards set out by regulatory authorities and the pharmaceuticals industry. Bova serves veterinary clinics and hospitals across the UK and in ten additional European markets through an online ordering system with deliveries within 24 hours. 

Nick Bova, founder and CEO of Bova, will continue to lead the company as part of Nextmune and Vimian.

Read more:

Recent news

Trinity Property Group joins Odevo

Fidelio’s international challenger in the property and housing management industry, Odevo, grows through the addition of Trinity Property Group. Trinity Property Group manages over 95,000 homes across England and Wales and has agreements for an additional 55,000 homes, making the

Read more

Odevo becomes SaaS supplier to leading Swedish pr…

Odevo, an international challenger in the property and housing management industry founded by Fidelio, has entered into an agreement with the housing developer JM. The agreement gives four Swedish management companies, managing a third of Sweden’s homeowner associations, access to

Read more

Odevo grows with fintech company Monu

Founded by Fidelio, Odevo continues to challenge the property and housing management industry. By acquiring the fintech company Monu, Odevo is now taking the step to offer its customers, i.e. property owners and homeowner associations, banking services within saving and

Read more